Statera Biopharma, Inc. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4a1d10c4-3bf5-4ad4-909b-c179229635cf/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-101.9M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-023703 |
| FY 2020 | $-12.1M | 2020-01-01 – 2020-12-31 | evidence 0001437749-22-023703 |
| FY 2019 | $-2.6M | 2019-01-01 – 2019-12-31 | evidence 0001437749-21-006758 |
| FY 2018 | $-3.6M | 2018-01-01 – 2018-12-31 | evidence 0001437749-20-007716 |
| FY 2013 | $-17.3M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-102607 |
| FY 2012 | $-18.2M | 2012-01-01 – 2012-12-31 | evidence 0001171843-13-001049 |
| FY 2011 | $-4.0M | 2011-01-01 – 2011-12-31 | evidence 0001171843-12-000908 |
| FY 2010 | $-26.4M | 2010-01-01 – 2010-12-31 | evidence 0001171843-12-000908 |
| FY 2009 | $-12.8M | 2009-01-02 – 2009-12-31 | evidence 0001171843-12-000908 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Statera Biopharma, Inc. — all facts · Revenue · Operating Income